Body Fluid Or Exudate Or Transudate Other Than Snake Venom, Feces, Urine, Or Semen (e.g., Lymph, Saliva, Honey, Royal Jelly, Digestive Juice, Etc.) Patents (Class 424/537)
  • Patent number: 5407675
    Abstract: A composition suitable for used on areas of the scalp and/or eyebrows in which hair loss is experienced and a method for applying the same. The composition includes a naturally occurring nutrient system such as naturally occurring honey, and a naturally occurring material capable as functioning as an epidermal stimulant such as an aqueous extract of leaves of Urtica dioica contained in a suitable carrier medium which is also, preferably compounded from naturally occurring products.
    Type: Grant
    Filed: August 10, 1990
    Date of Patent: April 18, 1995
    Inventor: Parviz Etemad-Moghadam
  • Patent number: 5403596
    Abstract: A novel anticoagulant/modulator factor isolated from the saliva of the meinal leech Hirudo medicinalis, specifically inhibiting bovine Xa factor but not inhibiting bovine thrombin.
    Type: Grant
    Filed: January 8, 1993
    Date of Patent: April 4, 1995
    Assignees: Yissum Research Development Company of the Hebrew University of Jerusalem, American National Red Cross
    Inventors: Meir Rigbi, Craig M. Jackson
  • Patent number: 5395851
    Abstract: A coating composition for application to tree wounds, such as pruning wounds of living trees is provided. The composition is non-phytotoxic and provides extended protection against fungal pathogens. The coating composition comprises a liquid carrier together with a fatty acid metal salt active ingredient. Exemplary fatty acid metal salts include those prepared from alpha monocarboxylic acids having from 4 to 18 carbon atoms and a compound containing a metal selected from the group consisting of calcium, copper, iron, magnesium, and zinc. Various additives can be included within the composition, including gum-like substances and binders suitable to facilitate the adhesion of the active ingredient to the tree surface, as well as defoaming agents and other formulation enhancing agents.
    Type: Grant
    Filed: July 16, 1993
    Date of Patent: March 7, 1995
    Assignee: W. Neudorff GmbH KG
    Inventor: Frederick S. Sedun
  • Patent number: 5277917
    Abstract: Herein described is an ovarian cancer activating factor that has been isolated from ovarian cancer ascites fluid. The factor may be utilized in its isolated form in a screening program aimed at identifying inhibitors of factor-mediated ovarian cancer activation, or as a growth supplement useful for culturing ovarian and other cancer cell lines.
    Type: Grant
    Filed: April 2, 1993
    Date of Patent: January 11, 1994
    Assignee: Allelix Biopharmaceuticals Inc.
    Inventors: Yan Xu, Anne E. Goodbody
  • Patent number: 5198230
    Abstract: This invention provides a recipe for making a detoxification medicine named DTS (Deities) for curing drug addiction. This DTS (Deities) medicine comprises no narcotic but mainly is made up by several kinds of effective ingredients of biological substances refined from various natural herbs and bioproducts. Drug addicts can be weaned and cured safely from addiction induced by Heroin, Cocaine, Morphine, Amphetamines, Hemp or Opium, and other substances within 7-30 days, by means of DTS (Deities) which can get rid of drug poisons present in an addict's blood and marrow. Further, DTS (Deities) can also be used to clear away tobacco tar and nicotine deposits so that it serves to wean from cigarette smoking as well.
    Type: Grant
    Filed: January 8, 1991
    Date of Patent: March 30, 1993
    Inventor: Liu C. Wen
  • Patent number: 5196204
    Abstract: Methods and compositions for blocking various channels and receptors within an organism are provided. For example, two toxins were isolated from the Agelenopsis aperta spider. The first toxin comprised a toxin having a molecular weight of from aproximately 5,000 to approximately 10,000. This toxin was found to have an irreversible effect on calcium channels within the central nervous system. A second toxin having a molecular weight of less than about 1,000 was also isolated. This toxin was found to have a reversible blocking effect on calcium channels within the central nervous system and the cardiovascular system.A third toxin was isolated from the Argiope aurantia spider. This toxin was found to have a reversible effect on excitatory amino acid receptors. Finally, a toxin having a molecular weight of from approximately 5,000 to approximately 7,000 daltons was isolated from the Hololena curta spider. This toxin was found to have an irreversible effect on excitatory amino acid receptors.
    Type: Grant
    Filed: November 12, 1991
    Date of Patent: March 23, 1993
    Assignee: University of Utah Research Foundation
    Inventors: J. R. Hunter Jackson, Thomas N. Parks
  • Patent number: 5183372
    Abstract: A service cart transportable in a van or truck is comprised of a vertically oriented pyramid-shaped profile. The pyramid shape offers a high degree of stability, making it virtually impossible to tip over during normal operating conditions, especially during transport. The cart has a fourwheel base. One set of wheels is preferably swivel casters for turning sharp corners. A second set of wheels is larger and located externally of the cart. These wheels increase the base of the pyramid profile and add to the cart's stability. The service cart may be transported to and from a job site. The cart fits into a van or truck bed. To remove the cart from the vehicle, a ramp system is provided. A mechanical or electrical winch may be used to transport the cart into or out of the vehicle.
    Type: Grant
    Filed: February 12, 1991
    Date of Patent: February 2, 1993
    Inventor: Daniel Dinverno
  • Patent number: 5182113
    Abstract: A novel anticoagulant/modulator factor isolated from the saliva of the medicinal leech Hirudo medicinalis, specifically inhibiting bovine Xa factor but not inhibiting bovine thrombin.
    Type: Grant
    Filed: June 23, 1989
    Date of Patent: January 26, 1993
    Assignee: Bio-Technology General Corp.
    Inventors: Meir Rigbi, Craig M. Jackson
  • Patent number: 5166320
    Abstract: A targetable gene delivery system is provided for introducing foreign genes into mammalian cells. The system employs a soluble targetable DNA complex and utilizes receptor-mediated endocytosis to endow cell specificity. The soluble DNA-carrying complex is formed by non-covalently binding a ligand conjugate with the foreign gene. The conjugate, in turn, is formed by bonding receptor-specific ligands such as asialoglycoproteins to polycations such as polylysine through covalent bonds such as disulfide bonds. The system exhibits a high degree of cell specificity and offers potential for the treatment of inherited genetic disorders.
    Type: Grant
    Filed: April 2, 1990
    Date of Patent: November 24, 1992
    Assignee: University of Connecticut
    Inventors: George Y. Wu, Catherine H. Wu
  • Patent number: 5122371
    Abstract: A biologically active agent extracted from female breast cyst fluids displays anti-hypertensive activity in mammals. The agent is also useful in the treatment of congestive heart disease, artial fibrillation and idiopathic edema in mammals.
    Type: Grant
    Filed: March 6, 1991
    Date of Patent: June 16, 1992
    Inventors: Fred I. Chaslow, H. Leon Bradlow
  • Patent number: 5122596
    Abstract: This invention relates to a polypeptide found to be present in the venom of the Agelenopsis aperta spider and to polypeptides having substantially the same amino acid sequence and substantially the same activity as said polypeptide. The polypeptides of this invention and the salts thereof block calcium channels in cells of various organisms and are useful in blocking said calcium channels in cells, per se; in the treatment of calcium channel mediated diseases and conditions; and in the control of invertebrate pests. This invention also relates to compositions comprising said polypeptides and salts thereof.
    Type: Grant
    Filed: September 29, 1989
    Date of Patent: June 16, 1992
    Assignee: Pfizer Inc.
    Inventors: Douglas Phillips, Nicholas A. Saccomano, Robert A. Volkmann
  • Patent number: 5098914
    Abstract: A method and composition for treating parasitic infestation of animals, including human beings, by the oral administration of a piperidine alkaloid composition over a period of days. Administration of Solenopsin A in an oral dosage form or whole body extract of the imported red fire ant, Solenopsis invicta, over a period of one to eleven days with regular booster dosages dissiminates the alkaloid composition through the blood and tissue fluids of the treated animals resulting in the elimination of blood and tissue-fluid feeding parasites.
    Type: Grant
    Filed: March 7, 1991
    Date of Patent: March 24, 1992
    Inventor: Chalmer V. Rehmert, Jr.
  • Patent number: 5064657
    Abstract: Methods and compositions for blocking various channels and receptors within an organism are provided. For example, a toxin was isolated from the Argiope aurantia spider. This toxin was found to have a reversible effect on excitatory amino acid receptors. Another toxin having a molecular weight of from approximately 5,000 to approximately 7,000 daltons was isolated from the Hololena curta spider. This toxin was found to have an irreversible effect on excitatory amino acid receptors.The present invention further relates to methods of treating heart and neurological diseases by applying the toxins isolated and identified. In particular, the low molecular weight toxin from Agelenopsis aperta may provide a treatment of certain heart conditions such as arrhythmia, angina, hypertension, and congestive heart failure. In addition, the toxins may provide beneficial effects on certain neuological conditions including seizures.
    Type: Grant
    Filed: May 11, 1990
    Date of Patent: November 12, 1991
    Assignee: University of Utah
    Inventors: J. R. Hunter Jackson, Thomas N. Parks
  • Patent number: 5028438
    Abstract: A biologically active agent extracted from female breast cyst fluids displays anti-hypertensive activity in mammals. The agent is also useful in the treatment of congestive heart disease, atrial fibrillation and idiopathic edema in mammals.
    Type: Grant
    Filed: December 9, 1987
    Date of Patent: July 2, 1991
    Assignee: Long Island Jewish Medical Center
    Inventors: Fred I. Chaslow, H. Leon Bradlow
  • Patent number: 4960592
    Abstract: A composition for the treatment of dry skin comprises a mixture of lanolin and lanolin oil. Preferably, the composition contains about 75% by weight of lanolin and about 25% by weight of lanolin oil.
    Type: Grant
    Filed: April 17, 1989
    Date of Patent: October 2, 1990
    Assignee: Lanocare Laboratories
    Inventors: Resheda Hagen, Gabriel Barnett
  • Patent number: 4950739
    Abstract: Nonpolypeptide factors isolated from the venom of funnel-web spiders are capable of binding calcium channel proteins. These nonpolypeptide factors are used to purify calcium channels and completely block voltage-dependant calcium conductance of cell membranes.
    Type: Grant
    Filed: July 14, 1988
    Date of Patent: August 21, 1990
    Assignee: New York University
    Inventors: Bruce D. Cherksey, Rodolfo R. Llinas, Mutsuyuki Sugimori
  • Patent number: 4925664
    Abstract: Methods and compositions for blocking various channels and receptors within an organism are provided. For example, two toxins were isolated from the Agelenopsis aperta spider. The first toxin comprised a toxin having a molecular weight of from approximately 5,000 to approximately 10,000. This toxin was found to have an irreversible effect on calcium channels within the central nervous system. A second toxin having a molecular weight of less than about 1,000 was also isolated. This toxin was found to have a reversible blocking effect on calcium channels within the central nervous system and the cardiovascular system.A third toxin was isolated from the Argiope aurantia spider. This toxin was found to have a reversible effect on excitatory amino acid receptors. Finally, a toxin having a molecular weight of from approximately 5,000 to approximately 7,000 daltons was isolated from the Hololena Curta spider. This toxin was found to have an irreversible effect on excitatory amino acid receptors.
    Type: Grant
    Filed: October 20, 1986
    Date of Patent: May 15, 1990
    Assignee: University of Utah
    Inventors: J. R. Hunter Jackson, Thomas N. Parks
  • Patent number: 4507483
    Abstract: 3-[(Substituted-amino)(aryl or heteroaryl)methyl]-1H-indoles which are useful as color-formers in pressure-sensitive carbonless duplicating systems and thermal marking systems are prepared by reacting 3-[(arylsulfonyl)(aryl or heteroaryl)methyl]-1H-indoles with amines or precursors thereof in the presence of a base.
    Type: Grant
    Filed: March 9, 1983
    Date of Patent: March 26, 1985
    Assignee: The Hilton-Davis Chemical Co.
    Inventors: Paul J. Schmidt, William M. Hung